Chemosensors (Aug 2021)

Aptamer-Sensitized Nanoribbon Biosensor for Ovarian Cancer Marker Detection in Plasma

  • Yuri D. Ivanov,
  • Kristina A. Malsagova,
  • Tatyana O. Pleshakova,
  • Rafael A. Galiullin,
  • Andrey F. Kozlov,
  • Ivan D. Shumov,
  • Vladimir P. Popov,
  • Svetlana I. Kapustina,
  • Irina A. Ivanova,
  • Arina I. Isaeva,
  • Fedor V. Tikhonenko,
  • Nikolay E. Kushlinskii,
  • Alexander A. Alferov,
  • Vadim Yu. Tatur,
  • Vadim S. Ziborov,
  • Oleg F. Petrov,
  • Alexander V. Glukhov,
  • Alexander I. Archakov

DOI
https://doi.org/10.3390/chemosensors9080222
Journal volume & issue
Vol. 9, no. 8
p. 222

Abstract

Read online

The detection of CA 125 protein in buffer solution with a silicon-on-insulator (SOI)-based nanoribbon (NR) biosensor was experimentally demonstrated. In the biosensor, sensor chips, bearing an array of 12 nanoribbons (NRs) with n-type conductance, were employed. In the course of the analysis with the NR biosensor, the target protein was biospecifically captured onto the surface of the NRs, which was sensitized with covalently immobilized aptamers against CA 125. Atomic force microscopy (AFM) and mass spectrometry (MS) were employed in order to confirm the formation of the probe–target complexes on the NR surface. Via AFM and MS, the formation of aptamer–antigen complexes on the surface of SOI substrates with covalently immobilized aptamers against CA 125 was revealed, thus confirming the efficient immobilization of the aptamers onto the SOI surface. The biosensor signal, resulting from the biospecific interaction between CA 125 and the NR-immobilized aptamer probes, was shown to increase with an increase in the target protein concentration. The minimum detectable CA 125 concentration was as low as 1.5 × 10−17 M. Moreover, with the biosensor proposed herein, the detection of CA 125 in the plasma of ovarian cancer patients was demonstrated.

Keywords